
Albert Mark Navarro
Examiner (ID: 439, Phone: (571)272-0861 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1621, 2899, 1817 |
| Total Applications | 2079 |
| Issued Applications | 1540 |
| Pending Applications | 155 |
| Abandoned Applications | 410 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16815781
[patent_doc_number] => 11000581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-11
[patent_title] => Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVs) for delivery to the GI-tract
[patent_app_type] => utility
[patent_app_number] => 16/086906
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 9
[patent_no_of_words] => 15442
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16086906
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/086906 | Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVs) for delivery to the GI-tract | Apr 27, 2017 | Issued |
Array
(
[id] => 12403524
[patent_doc_number] => 09968098
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Synergistic
[patent_app_type] => utility
[patent_app_number] => 15/498647
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6399
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15498647
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/498647 | Synergistic | Apr 26, 2017 | Issued |
Array
(
[id] => 12021508
[patent_doc_number] => 20170311607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'SYNERGISTIC BACILLUS THURINGIENSIS SUBSP. AIZAWAI, BACILLUS THURINGIENSIS SUBSP. KURSTAKI AND FLUBENDIAMIDE MIXTURES FOR DIAMONDBACK MOTH, SUGARCANE BORER, SOYBEAN LOOPER, AND CORN EARWORM'
[patent_app_type] => utility
[patent_app_number] => 15/498635
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6485
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15498635
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/498635 | SYNERGISTIC BACILLUS THURINGIENSIS SUBSP. AIZAWAI, BACILLUS THURINGIENSIS SUBSP. KURSTAKI AND FLUBENDIAMIDE MIXTURES FOR DIAMONDBACK MOTH, SUGARCANE BORER, SOYBEAN LOOPER, AND CORN EARWORM | Apr 26, 2017 | Abandoned |
Array
(
[id] => 12021506
[patent_doc_number] => 20170311605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'SYNERGISTIC BACILLUS THURINGIENSIS SUBSP. AIZAWAI AND FLUBENDIAMIDE MIXTURES FOR DIAMONDBACK MOTH, BEET ARMYWORM, SOYBEAN LOOPER, CORN EARWORM, AND SUGARCANE BORER CONTROL'
[patent_app_type] => utility
[patent_app_number] => 15/498623
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6028
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15498623
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/498623 | SYNERGISTIC BACILLUS THURINGIENSIS SUBSP. AIZAWAI AND FLUBENDIAMIDE MIXTURES FOR DIAMONDBACK MOTH, BEET ARMYWORM, SOYBEAN LOOPER, CORN EARWORM, AND SUGARCANE BORER CONTROL | Apr 26, 2017 | Abandoned |
Array
(
[id] => 17670982
[patent_doc_number] => 20220184149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => BACTERIOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/094856
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094856
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094856 | Bacteriotherapy | Apr 18, 2017 | Issued |
Array
(
[id] => 14342221
[patent_doc_number] => 20190153083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => NOVEL PEPTIDE STRUCTURES AND USE THEREOF IN THE TREATMENT OF TOXOPLASMOSIS
[patent_app_type] => utility
[patent_app_number] => 16/093215
[patent_app_country] => US
[patent_app_date] => 2017-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093215
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093215 | NOVEL PEPTIDE STRUCTURES AND USE THEREOF IN THE TREATMENT OF TOXOPLASMOSIS | Apr 10, 2017 | Abandoned |
Array
(
[id] => 11834657
[patent_doc_number] => 20170216377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM'
[patent_app_type] => utility
[patent_app_number] => 15/484842
[patent_app_country] => US
[patent_app_date] => 2017-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15461
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15484842
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/484842 | Method of identifying a biologically-active composition from a biofilm | Apr 10, 2017 | Issued |
Array
(
[id] => 14199439
[patent_doc_number] => 10266816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Carrier for targeting nerve cells
[patent_app_type] => utility
[patent_app_number] => 15/481645
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7255
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1506
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15481645
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/481645 | Carrier for targeting nerve cells | Apr 6, 2017 | Issued |
Array
(
[id] => 14019425
[patent_doc_number] => 20190071706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/091039
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24978
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091039
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091039 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING DISEASE | Apr 3, 2017 | Abandoned |
Array
(
[id] => 14210737
[patent_doc_number] => 20190117753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => OMPA IN VACCINE COMPOSITIONS AND AS DIAGNOSTIC TARGETS
[patent_app_type] => utility
[patent_app_number] => 16/090708
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090708
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090708 | OMPA IN VACCINE COMPOSITIONS AND AS DIAGNOSTIC TARGETS | Mar 28, 2017 | Abandoned |
Array
(
[id] => 11971442
[patent_doc_number] => 20170275596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'COMPOSITION AND METHOD FOR TREATING ANDROGEN-DEPENDENT DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/471194
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20504
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471194
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/471194 | Composition and method for treating androgen-dependent disorders | Mar 27, 2017 | Issued |
Array
(
[id] => 14158721
[patent_doc_number] => 20190106463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => ENGINEERED POLYPEPTIDES FOR ANTIGEN DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/087215
[patent_app_country] => US
[patent_app_date] => 2017-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087215
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/087215 | Engineered polypeptides for antigen delivery | Mar 22, 2017 | Issued |
Array
(
[id] => 16924064
[patent_doc_number] => 11045520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Compositions and methods for topical delivery of pharmaceutical agents
[patent_app_type] => utility
[patent_app_number] => 16/086947
[patent_app_country] => US
[patent_app_date] => 2017-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 9621
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16086947
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/086947 | Compositions and methods for topical delivery of pharmaceutical agents | Mar 21, 2017 | Issued |
Array
(
[id] => 16635291
[patent_doc_number] => 10913786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-09
[patent_title] => Compositions and methods for inhibiting Wnt signaling
[patent_app_type] => utility
[patent_app_number] => 16/086159
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 76
[patent_no_of_words] => 34602
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16086159
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/086159 | Compositions and methods for inhibiting Wnt signaling | Mar 20, 2017 | Issued |
Array
(
[id] => 12466314
[patent_doc_number] => 09987346
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Methods and compositions for vaccinating a subject for a sexually transmitted pathogen
[patent_app_type] => utility
[patent_app_number] => 15/448767
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 46
[patent_no_of_words] => 13071
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15448767
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/448767 | Methods and compositions for vaccinating a subject for a sexually transmitted pathogen | Mar 2, 2017 | Issued |
Array
(
[id] => 11935191
[patent_doc_number] => 20170239340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/421808
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 32939
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15421808
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/421808 | Isolated polypeptide of the toxin A and toxin B proteins of | Jan 31, 2017 | Issued |
Array
(
[id] => 12098226
[patent_doc_number] => 09855303
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-02
[patent_title] => 'Compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 15/415745
[patent_app_country] => US
[patent_app_date] => 2017-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 69915
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15415745
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/415745 | Compositions and methods | Jan 24, 2017 | Issued |
Array
(
[id] => 13867497
[patent_doc_number] => 20190030089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => FAECALIBACTERIUM PRAUSNITZII STRAIN CNCM 1-4573 FOR THE TREATMENT AND PREVENTION OF GASTROINTESTINAL INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 16/072319
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16072319
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/072319 | None | Jan 22, 2017 | Issued |
Array
(
[id] => 12246248
[patent_doc_number] => 09919012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-20
[patent_title] => 'Method of identifying a biologically-active composition from a biofilm'
[patent_app_type] => utility
[patent_app_number] => 15/412712
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15446
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15412712
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/412712 | Method of identifying a biologically-active composition from a biofilm | Jan 22, 2017 | Issued |
Array
(
[id] => 13843633
[patent_doc_number] => 20190025301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => Method And Kit For Diagnosis Of Active Tuberculosis
[patent_app_type] => utility
[patent_app_number] => 16/071639
[patent_app_country] => US
[patent_app_date] => 2017-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071639
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071639 | Method And Kit For Diagnosis Of Active Tuberculosis | Jan 17, 2017 | Abandoned |